sacituzumab govitecan,Pembrolizumab,Carboplatin,Cisplatin
Gilead sciences,merck
['sclc', 'lcsm,(-blcsm)', 'lung', 'breast', 'urothelial', 'nsclc']
dr. edward garon, member of lungevity s scientific advisory board, presents poster about evoke 02 - an international phase 2 study of a drug-antibody conjugate in #nsclc (already fda-approved for treating breast &amp; urothelial cancers). currently enrolling. #asco22 #lcsm 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.